Pathway Pharmaceuticals
Latest round
- Seed
Last raised
- Apr 2014
Total raised
- Undisclosed
Investors
- 1
About Pathway Pharmaceuticals
Pathway Pharmaceuticals is dedicated to advancing healthcare by developing innovative therapeutic solutions.Pathway Pharmaceuticals operates as a pharmaceutical company that focuses on developing targeted therapies for cancer treatment. The firm is headquartered in Hong Kong, Hong Kong. Anton Buzdin serves as the CEO of the company.Pathway Pharmaceuticals specializes in providing innovative therapeutic solutions aimed at enhancing treatment options for patients with various cancers. Their core product offerings include therapies designed to target specific cancer types, improving treatment outcomes and patient quality of life. The company primarily serves healthcare providers and institutions focused on oncology, ensuring that its solutions address significant medical needs in the market.Pathway Pharmaceuticals generates revenue predominantly through partnerships and licensing agreements with healthcare institutions and pharmaceutical companies. The revenue model is based on long-term contracts and collaborations, with clients committing to ongoing access to their therapeutic solutions. The pricing structure is designed to cater to various client needs, with different tiers available depending on the extent of services and products required.Looking ahead, Pathway Pharmaceuticals plans to launch new therapeutic products targeting additional cancer types by the end of 2024. The company is also focused on expanding its reach into new geographical markets, particularly in Europe and Asia, over the next two years.
Who invested in Pathway Pharmaceuticals
1 investor across 1 round
See all investors in Pathway Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 16, 2014
Amount
Undisclosed
Investors
Questions about Pathway Pharmaceuticals
Who invested in Pathway Pharmaceuticals?
Pathway Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pathway Pharmaceuticals raised?
Pathway Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pathway Pharmaceuticals last raise money?
Pathway Pharmaceuticals's most recent round on record is a Seed, in Apr 2014.
What does Pathway Pharmaceuticals do?
Pathway Pharmaceuticals is dedicated to advancing healthcare by developing innovative therapeutic solutions.
Where is Pathway Pharmaceuticals headquartered?
Pathway Pharmaceuticals is headquartered in Hong Kong, Hong Kong SAR - China.
Which VCs invest in companies like Pathway Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Pathway Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Pathway Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.